tradingkey.logo
tradingkey.logo
Search

Radiance Biopharma Signs Exclusive License For 'First In Class' Nano Antibody ADC

ReutersSep 3, 2025 9:47 PM
facebooktwitterlinkedin

-

  • RADIANCE BIOPHARMA SIGNS EXCLUSIVE LICENSE FOR 'FIRST IN CLASS' C-MET/EGFR TARGETED NANO ANTIBODY ADC

  • RADIANCE BIOPHARMA: TO PAY NOVATIM UPFRONT PAYMENT OF USD$15 MILLION, UP TO $150 MILLION IN POTENTIAL DEVELOPMENT & REGULATORY MILESTONE PAYMENTS

  • RADIANCE BIOPHARMA: WILL PAY NOVATIM OVER $1 BILLION IN POTENTIAL COMMERCIAL MILESTONE PAYMENTS

Further company coverage: [ ]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI